Liquidia

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Liquidia and other ETFs, options, and stocks.

About LQDA

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC. 

CEO
Roger A. Jeffs
CEORoger A. Jeffs
Employees
157
Employees157
Headquarters
Morrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded
2004
Founded2004
Employees
157
Employees157

LQDA Key Statistics

Market cap
2.67B
Market cap2.67B
Price-Earnings ratio
-19.86
Price-Earnings ratio-19.86
Dividend yield
Dividend yield
Average volume
3.03M
Average volume3.03M
High today
$30.69
High today$30.69
Low today
$27.99
Low today$27.99
Open price
$28.05
Open price$28.05
Volume
3.46M
Volume3.46M
52 Week high
$30.69
52 Week high$30.69
52 Week low
$9.71
52 Week low$9.71

Stock Snapshot

With a market cap of 2.67B, Liquidia(LQDA) trades at $30.68. The stock has a price-to-earnings ratio of -19.86.

On 2025-11-18, Liquidia(LQDA) stock traded between a low of $27.99 and a high of $30.69. Shares are currently priced at $30.68, which is +9.6% above the low and -0.0% below the high.

Liquidia(LQDA) shares are trading with a volume of 3.46M, against a daily average of 3.03M.

In the last year, Liquidia(LQDA) shares hit a 52-week high of $30.69 and a 52-week low of $9.71.

In the last year, Liquidia(LQDA) shares hit a 52-week high of $30.69 and a 52-week low of $9.71.

LQDA News

The Motley Fool 1d
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch

This biotech-focused fund made a big bet on Liquidia just as the company's YUTREPIA drug notched its first full quarter of commercialization. California-based...

This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch
Simply Wall St 3d
A Fresh Look at Liquidia Valuation Following Strong Q3 Revenue Growth and Narrowed Net Loss

Liquidia (LQDA) just released its third quarter results, revealing revenue that jumped significantly from last year and a net loss that narrowed sharply compare...

A Fresh Look at Liquidia Valuation Following Strong Q3 Revenue Growth and Narrowed Net Loss
Simply Wall St 4d
Why Liquidia Is Up 5.2% After Posting Substantial Q3 Revenue Growth and Reduced Losses

Liquidia Corporation recently reported its third quarter 2025 earnings, revealing US$54.34 million in revenue and a net loss of US$3.53 million, compared to US$...

Why Liquidia Is Up 5.2% After Posting Substantial Q3 Revenue Growth and Reduced Losses

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
0%
Sell
11.1%

People also own

Based on the portfolios of people who own LQDA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.